Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention

Recent Results in Cancer Research

Volumn 164, Issue , 2003, Pages 413-425

  Cross, Heide S ^a   Kállay, Enikö ^a   Farhan, Hesso ^a   Weiland, Tina ^a   Manhardt, Theresa ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYTOCHROME P450 FAMILY 24; CYTOCHROME P450 FAMILY 27; CYTOCHROME P450 FAMILY 27 B1; ESTRADIOL; GENISTEIN; MESSENGER RNA; PHYTOESTROGEN; RNA 18S; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCIDIOL 1 MONOOXYGENASE; CYTOCHROME P450; ESTROGEN; ISOFLAVONE DERIVATIVE; PLANT MEDICINAL PRODUCT; SOYBEAN PROTEIN; STEROID MONOOXYGENASE; VITAMIN D; VITAMIN D 24 HYDROXYLASE; VITAMIN D 24-HYDROXYLASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CACO-2 CELL LINE; CANCER GRADING; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CELL DIFFERENTIATION; COLON CANCER; COLON CANCER CELL LINE; COLON CELL; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; EXTRARENAL VITAMIN D METABOLISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METABOLIC REGULATION; MOLECULAR DYNAMICS; NEGATIVE FEEDBACK; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SYNTHESIS; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; VITAMIN SYNTHESIS; WESTERN BLOTTING; CHEMISTRY; COLON; COLON TUMOR; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; PROSTATE TUMOR; PROTEIN INTAKE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; COLON; COLONIC NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; DIETARY PROTEINS; ESTROGENS, NON-STEROIDAL; GENE EXPRESSION; GENISTEIN; HUMANS; ISOFLAVONES; MALE; PHYTOESTROGENS; PLANT PREPARATIONS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOYBEAN PROTEINS; STEROID HYDROXYLASES; VITAMIN D;

EID: 0642305911     PISSN: 00800015     EISSN: 21976767     Source Type: Book Series    
DOI: 10.1007/978-3-642-55580-0_30     Document Type: Article

References (27)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595
2. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray J W, Pinkel D (2000) Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25:144-146
3. Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M (2001) 25-hydroxyvitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 285:1012-1017
4. Bareis P, Kallay E, Bischof MG, Bises G, Hofer H, Pötzi C, Manhardt T, Bland R, Cross HS (2002) Clonal differences in expression of 25-hydroxyvitamin D3-1a-hydroxylase, of 25-hydroxyvitamin D3-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1a,25-dihydroxyvitamin D3. Exp Cell Res 276:320-327
5. Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N (1993) Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2:467-472
6. Cross HS, Pavelka M, Slavik J, Peterlik M (1992) Growth control of human colon cancer cells by vitamin D and calcium in vitro. J Natl Cancer Inst 84:1355-1357
7. Cross HS, Peterlik M, Reddy GS, Schuster I (1997) Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1a-hydroxylase activity and regulation of side chain metabolism. J Steroid Biochem Mol Biol 62:21-28
8. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E, Peterlik M (2001) 25-hydroxyvitamin D3-1a-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66:287-292
9. Farhan H, Wähälä K, Adlercreutz H, Cross HS (2002) Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells. J Chromatography B 777:261-268
10. Garland CF, Garland FC (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9:227-231
11. Garland FC, Garland CF, Gorham ED, Young J F (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19:614-622
12. Grant WB (2002) An estimate of premature cancer mortality in the United States due to inadequate doses of solar ultraviolet-B radiation. Cancer 94:1867-1875
13. Hanchette CL, Schwartz GG (1992) Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70:2861-2869
14. Hofer H, Ho G-M, Peterlik M, Uskokovic MR, Lee JK, White MC, Posner, Cross HS (1999) Biological effects of 1a-hydroxy-and 1b-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapy. J Pharmacol Exp Ther 291:450-455
15. Kallay E, Pietschmann P, Toyokuni S, Bajna E, Hahn P, Mazzucco K, Bieglmayer C, Kato S, Cross HS (2001) Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22:1429-1435
16. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafson JA, Smithies O (1998) Generation and reproductive phenotypes of mice lacking estrogen receptor b. Proc Natl Acad Sci U S A 95:15677-15682
17. Kuiper GJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Endocrinol 139:4252-4263
18. Lau KM, LaSpina M, Long J, Ho SM (2000) Expression of estrogen receptor (ER)-a and ER-b in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res 60:3175-3182
19. Ly LH, Zhao X-Y, Holloway L, Feldman D (1999) Liarozole acts synergistically with 1,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology 140:2071-2076
20. Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, Jacquemin-Sablon A, Saucier JM, Le Pecq JB, Larsen AK (1989) Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 49:5111-5117
21. Nesby-O’Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, Allen C, Doughertly C, Gunter EW, Bowman BA (2002) Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 76:187-192
22. Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF (1998) Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 7:391-395
23. Sheinin Y, Kaserer K, Wrba F, Wenzl E, Kriwanek S, Peterlik M, Cross HS (2000) In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression. Virchows Arch 437:501-507
24. Smirnoff P, Liel Y, Gnainsky J, Shany S, Schwartz B (1999) The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncol Res 11: 255-264
25. Swami S, Krishnan AV, Feldman D (2000) 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res 6:3371-3379
26. Tuohimaa P, Lyakhovich A, Aksenov N, Pennanen P, Syvala H, Lou YR, Ahonen M, Hasan T, Pasanen P, Blauer M et al (2001) Vitamin D and prostate cancer. J Steroid Biochem Mol Biol 76:125-134
27. World Cancer Research Fund and American Institute for Cancer Research (1997) Food, nutrition and the prevention of cancer: a global perspective. World Cancer Research Fund and American Institute for Cancer Research, Washington, DC